Stephen Langabeer. 2022. “Molecular Screening for an Underlying Myeloproliferative Neoplasm in Rheumatology Patients”. Archives of Rheumatology 37 (3):475-76. https://doi.org/10.46497/ArchRheumatol.2022.9274.